In line with our data, LAG-3 expression may be a potential mechanism of immune evasion in PDAC, especially since in non-small cell lung carcinoma (NSCLC) prominent LAG-3 expression by T cells was associated with insensitivity to PD-1 blockade [39]. The gene discussed is LAG3; the disease is non-small cell lung carcinoma.